CIK 0001630627
- Accelerated filer
TREACE MEDICAL CONCEPTS, INC.
Sign in to watch- Ticker
- TMCI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- Operating
- EIN
- 471052611
- Phone
- +1 904-373-5940
- Business address
- 100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
- Open-market buys, last 90 days
- $47,731
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$47,731. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-12 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion | +33,750 | $0.10 | $3K | 250,074 |
| 2024-09-12 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion · Stock Option (Right to Buy) | −33,750 | 0 | ||
| 2024-08-09 | Scanlan Sean F. Chief Innovation Officer | Grant or award | +120,900 | 216,324 | ||
| 2024-03-10 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −1,396 | 95,424 | ||
| 2024-03-08 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −389 | 96,820 | ||
| 2024-01-10 | Scanlan Sean F. Chief Innovation Officer | Grant or award | +65,025 | 97,209 | ||
| 2024-01-10 | Scanlan Sean F. Chief Innovation Officer | Grant or award · Stock Option (Right to Buy) | +73,200 | 73,200 | ||
| 2023-11-02 | Scanlan Sean F. Chief Innovation Officer | Shares withheld for taxes | −211 | 32,184 | ||
| 2023-05-16 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion | +25,000 | $0.10 | $3K | 57,395 |
| 2023-05-16 | Scanlan Sean F. Chief Innovation Officer | Sale | −25,000 | $25.44 | $636K | 32,395 |
| 2023-05-16 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 33,750 | ||
| 2023-03-10 | Scanlan Sean F. Chief Innovation Officer | Grant or award | +22,925 | 32,395 | ||
| 2023-03-10 | Scanlan Sean F. Chief Innovation Officer | Grant or award · Stock Option (Right to Buy) | −51,950 | 51,950 | ||
| 2023-03-09 | Scanlan Sean F. Chief Innovation Officer | Sale | −505 | $24.41 | $12K | 9,470 |
| 2023-02-15 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion | +25,000 | $0.10 | $3K | 34,975 |
| 2023-02-15 | Scanlan Sean F. Chief Innovation Officer | Sale | −25,000 | $21.69 | $542K | 9,975 |
| 2023-02-15 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | $0.10 | $3K | 58,750 |
| 2023-01-12 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion | +25,000 | $0.10 | $3K | 34,975 |
| 2023-01-12 | Scanlan Sean F. Chief Innovation Officer | Sale | −25,000 | $25.57 | $639K | 9,975 |
| 2023-01-12 | Scanlan Sean F. Chief Innovation Officer | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | $0.10 | $3K | 83,750 |
Page 2 of 3 · 45 trades